Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Dyslipemia")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 10765

  • Page / 431

Export

Selection :

  • and

PCSK9 : a promising therapeutic target for dyslipidemias?LAMBERT, Gilles; KREMPF, Michel; COSTET, Philippe et al.Trends in endocrinology and metabolism. 2006, Vol 17, Num 3, pp 79-81, issn 1043-2760, 3 p.Article

Pathophysiology and types of dyslipidemia in PCOS : Polycystic ovary syndromeDIAMANTI -KANDARAKIS, Evanthia; PAPAVASSILIOU, Athanasios G; KANDARAKIS, Stylianos A et al.Trends in endocrinology and metabolism. 2007, Vol 18, Num 7, pp 280-285, issn 1043-2760, 6 p.Article

Update on dyslipidemiaGARG, Abhimanyu; SIMHA, Vinaya.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 5, pp 1581-1589, issn 0021-972X, 9 p.Article

Les dyslipidémiesFARNIER, M.La Lettre du cardiologue. 2005, Num 385, pp 29-33, issn 0761-5035, 5 p., SUPConference Paper

Diagnostic d'une hyperlipidémie en 2001GONBERT, Sophie; BRUCKERT, Eric; TURPIN, Gérard et al.MTE. Médecine thérapeutique endocrinologie. 2001, Vol 3, Num 6, pp 430-439, issn 1295-9359Article

A 52-Week Placebo-Controlled Trial of Evolocumab in HyperlipidemiaBLOM, Dirk J; HALA, Tomas; MONSALVO, Maria Laura et al.The New England journal of medicine. 2014, Vol 370, Num 19, pp 1809-1819, issn 0028-4793, 11 p.Article

Le traitement des hyperlipidémiesCHAGNON, André.Concours médical (Paris). 2006, Vol 128, Num 6-7, pp 283-287, issn 0010-5309, 5 p.Article

British Hyperlipidaemia Association. Annual General Scientific MeetingAtherosclerosis. 1998, Vol 141, Num 1, pp 181-187, issn 0021-9150Conference Proceedings

British Hyperlipidaemia Association. Annual General Scientific MeetingAtherosclerosis. 1997, Vol 135, Num 1, pp 131-137, issn 0021-9150Conference Proceedings

DYSLIPIDÉMIES = DyslipidemiaLE BRAS, Maëlle; CARIOU, Bertrand.La Revue du praticien (Paris). 2011, Vol 61, Num 1, pp 93-102, issn 0035-2640, 10 p.Article

CoLaus: diabète et dyslipidémie, il y a toujours du nouveau! : MEDECINE INTERNE = CoLaus: diabetes and dyslipidemia, there is always something new!VOLLENWEIDER, P; VAUCHER, J; BASTARDOT, F et al.Revue médicale suisse. 2011, Vol 7, Num 315, issn 1660-9379, 2122-2126 [4 p.]Article

Hypercholestérolémie : attitudes et pratiques des omnipraticiens lavallois = Hypercholesterolemia: attitudes and practices of general practitioners in Laval, QuebecLAURIER, D; MAHEUX, B.Union médicale du Canada. 1993, Vol 122, Num 3, pp 176-182, issn 0041-6959, 6 p.Conference Paper

A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemiaHUERTAS-VAZQUEZ, Adriana; PLAISIER, Christopher L; PAJUKANTA, Päivi et al.Human genetics. 2010, Vol 127, Num 1, pp 83-89, issn 0340-6717, 7 p.Article

La lipémie rétinienne: mode de découverte d'une hypertriglycéridémie majeure = Lipemia retinalis: A sign of a severe hypertriglyceridemiaTHERON, F; BEYNAT, J; BRINDISI, M.-C et al.Journal français d'ophtalmologie. 2010, Vol 33, Num 1, pp 72-74, issn 0181-5512, 3 p.Article

Common variants at 30 loci contribute to polygenic dyslipidemiaKATHIRESAN, Sekar; WILLER, Cristen J; VOIGHT, Benjamin F et al.Nature genetics. 2009, Vol 41, Num 1, pp 56-65, issn 1061-4036, 10 p.Article

Effectiveness and tolerability of Simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)GRUNDY, Scott M; VEGA, Gloria L; ZHONG YUAN et al.The American journal of cardiology. 2005, Vol 95, Num 4, pp 462-468, issn 0002-9149, 7 p.Article

A symposium: Charting the universe in dyslipidemia managementBREWER, H. Bryan.The American journal of cardiology. 2003, Vol 92, Num 4B, issn 0002-9149, 31 p.Conference Proceedings

Ce qui a changé dans la prise en charge des hyperlipidémies = HyperlipidemiaFARNIER, Michel.Concours médical (Paris). 2002, Vol 124, Num 1, pp 27-28, issn 0010-5309Article

Prise en charge thérapeutique du patient dyslipidémique = Dyslipemia managementConcours médical (Paris). 2001, Vol 123, Num 12, pp 832-836, issn 0010-5309Article

Dyslipidémie et diabète = Dyslipidemia and diabetesCAULFIELD, A; PHILIPPE, J.Médecine et hygiène. 1997, Vol 55, Num 2167, pp 1222-1225, issn 0025-6749Conference Paper

Pharmacogenomics, Lipid Disorders, and Treatment OptionsGRYN, S. E; HEGELE, R. A.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 36-47, issn 0009-9236, 12 p.Article

Carbohydrate Nutrition Differs by Diabetes Status and Is Associated with Dyslipidemia in Boston Puerto Rican Adults without DiabetesVAN ROMPAY, Maria I; MCKEOWN, Nicola M; CASTANEDA-SCEPPA, Carmen et al.The Journal of nutrition. 2013, Vol 143, Num 2, pp 182-188, issn 0022-3166, 7 p.Article

Dietary lipid modification for mild and severe dyslipidaemias : Transforming the nutrition landscape in AfricaMARAIS, A. David.Proceedings of the Nutrition Society. 2013, Vol 72, Num 3, pp 337-341, issn 0029-6651, 5 p.Conference Paper

Recommandations de l'ESC sur les dyslipidémies: Que faut-il retenir ?Diabète & obésité. 2012, Vol 7, Num 55, pp 24-29, issn 1957-5238, 6 p.Article

Dyslipidemias in children and adolescentsHERSBERGER, Martin.Clinical biochemistry. 2011, Vol 44, Num 7, pp 507-508, issn 0009-9120, 2 p.Article

  • Page / 431